The cannabis industry is poised for significant evolution in 2026, driven by shifting consumer preferences, emerging markets, and the ongoing debate surrounding federal legalization in the United States. Stakeholders are bracing for a landscape shaped by increased competition, evolving product innovation, and a complex regulatory environment. Key Highlights: Expansion into new product categories beyond traditional…
Embarking on your first cannabis cultivation journey is an exciting prospect, offering the reward of homegrown, quality bud. This guide demystifies the process for beginners, focusing on essential steps from seed to harvest. Key Highlights: Selecting the right strain is crucial for beginners, with autoflowering varieties often recommended for their ease of care. Indoor growing…
The Revelry Buyers Club NY has emerged as a pivotal industry conference in New York City, fostering significant connections and discussions within the burgeoning cannabis sector. This premier event gathered key stakeholders, from cultivators and processors to retailers and investors, to navigate the evolving landscape of legal cannabis in one of the nation’s most significant…
The cannabis stock market is experiencing a notable upswing, with investor interest building rapidly. This renewed attention signals a potential shift in market sentiment, driven by evolving regulatory landscapes and increasing institutional acknowledgment of the sector’s growth potential. Analysts are closely watching key players as the watchlist for promising cannabis companies expands. Renewed Investor Enthusiasm:…
The White House has escalated pressure on federal agencies to expedite the rescheduling of cannabis, a move driven by growing concerns over the drug’s increasing potency and potential public health risks. This intensified focus signals a potential shift in federal drug policy, moving away from a long-standing prohibitionist stance towards a more nuanced approach that…
The White House has issued a stern warning regarding the marketing practices of high-potency cannabis products, signaling increased federal scrutiny on the burgeoning industry. This move suggests a potential shift in the regulatory landscape as concerns mount over public health and the appeal of these potent products, particularly to young people. Key Highlights: Federal government…
In a strategic move to address the persistent ‘data desert’ surrounding medical cannabis, Duquesne University’s Nasuti College of Osteopathic Medicine has entered into a formal research partnership with Pittsburgh-based Terra Pharm. This collaboration, which bridges the gap between academic rigor and commercial clinical application, seeks to provide the evidence-based data necessary to validate cannabinoid-based therapies…
The federal government’s historic decision to move marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA) represents the most significant shift in American drug policy in over five decades. This reclassification, finalized after years of advocacy and scientific review, fundamentally alters how the United States treats cannabis, moving it from a…
Canopy Growth Corporation (TSX: WEED, Nasdaq: CGC) has launched an aggressive revitalization of its flagship cannabis brand, Tweed, just in time for the Canadian summer. Centered around the “There’s a Tweed for That” campaign and featuring consumer-requested packaging improvements, the strategic maneuver aims to capture market share through enhanced visibility, potency, and pricing. By leveraging…
Twofold™, a new premium spirits-format THC brand, officially launched on April 20, 2026, marking a significant evolution in the social consumption of cannabis. By introducing a 750ml bottle designed specifically for cocktail integration, the brand seeks to bridge the gap between traditional mixology and the rapidly expanding market for alternative social beverages. The product offers…
